Cargando…
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival
Unlike lung adenocarcinoma, little progress has been made in the treatment of squamous cell lung carcinoma (SCC). The Cancer Genome Atlas (TCGA) has recently reported that receptor tyrosine kinase signaling pathways are altered in 26% of SCC tumors, validating the importance of downstream Signal Tra...
Autores principales: | Abbas, Rime, McColl, Karen S, Kresak, Adam, Yang, Michael, Chen, Yanwen, Fu, Pingfu, Wildey, Gary, Dowlati, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380958/ https://www.ncbi.nlm.nih.gov/pubmed/25573684 http://dx.doi.org/10.1002/cam4.372 |
Ejemplares similares
-
Post‐transcriptional regulation of PIAS3 expression by miR‐18a in malignant mesothelioma
por: He, Tian, et al.
Publicado: (2018) -
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer
por: McColl, Karen, et al.
Publicado: (2017) -
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016) -
Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer
por: He, Tian, et al.
Publicado: (2020) -
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer
por: Bhateja, Priyanka, et al.
Publicado: (2019)